CVE-2023-22868

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.
References
Configurations

Configuration 1 (hide)

AND
OR cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*
cpe:2.3:a:ibm:aspera_faspex:4.4.1:patch_level_1:*:*:*:*:*:*
OR cpe:2.3:o:linux:linux_kernel:-:*:*:*:*:*:*:*
cpe:2.3:o:microsoft:windows:-:*:*:*:*:*:*:*

History

07 Nov 2023, 04:07

Type Values Removed Values Added
Summary IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117. IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

Information

Published : 2023-02-17 17:15

Updated : 2024-02-28 19:51


NVD link : CVE-2023-22868

Mitre link : CVE-2023-22868

CVE.ORG link : CVE-2023-22868


JSON object : View

Products Affected

ibm

  • aspera_faspex

linux

  • linux_kernel

microsoft

  • windows
CWE
CWE-79

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')